What Is Sleep Apnea?
Sleep apnea is when your breathing stops repeatedly during sleep—sometimes dozens or even hundreds of times per night. Each time your airway closes, your oxygen level drops, and your brain wakes you up just enough to gasp for air. You might not remember these brief awakenings, but your body experiences them all night long.
Sleep apnea is serious and affects millions of people worldwide. Unfortunately, many people don't know they have it. The consequences reach far beyond just poor sleep.
Untreated sleep apnea increases your risk of high blood pressure, heart attack, stroke, and sudden cardiac death. Beyond physical health, it causes daytime fatigue, memory problems, mood changes, and relationship issues. But sleep apnea is treatable, and getting help can save your life and dramatically improve your quality of life.
OSA Pathophysiology and Airway Collapse
During wakefulness, upper airway patency is maintained through continuous contraction of pharyngeal dilator muscles, including the genioglossus, soft palate muscles, and pharyngeal constrictor muscles. These muscles are innervated primarily by the hypoglossal nerve (cranial nerve XII) and receive tonic activity throughout wakefulness.
During sleep, muscle tone systematically decreases across skeletal muscles. Pharyngeal dilator muscles also experience reduced tone during non-rapid eye movement sleep and even more pronounced reductions during rapid eye movement (REM) sleep. This physiological reduction in airway muscle tone predisposes to airway narrowing and obstruction in predisposed individuals.
Airway obstruction occurs when the collapsing pressure exceeds the pharyngeal muscle dilating pressure. The airway collapse typically occurs at the level of the oropharynx, at or posterior to the soft palate. The tongue base is pushed posteriorly, narrowing the airway lumen. This obstruction results in cessation of airflow (apnea) or significant airflow reduction (hypopnea), leading to oxygen desaturation.
The apnea-hypopnea index (AHI), defined as the number of apneas and hypopneas occurring per hour of sleep, stratifies disease severity. Mild OSA is defined as AHI 5-14 events/hour, moderate as AHI 15-29 events/hour, and severe as AHI >30 events/hour. Each obstructive episode typically continues 10-60 seconds before arousal occurs, restorative pharyngeal muscle tone returns, and breathing resumes.
Upper Airway Anatomy and Predisposing Factors
Multiple anatomical factors contribute to OSA susceptibility and severity. Anatomical assessment incorporates both skeletal structures and soft tissue traits.
Skeletal anatomy much influences airway dimensions and collapsibility. Retrognathia (posterior mandibular position), micrognathia (small mandible), maxillary retrusion, and increased cranial base angle all reduce the sagittal dimension of the oropharynx, predisposing to obstruction. These skeletal traits frequently manifest in patients with OSA when compared to matched controls.
Soft tissue factors include tonsillar hypertrophy, adenoidal enlargement, uvular edema, and soft palate thickening. Enlarged tonsils and adenoids physically narrow the oropharyngeal airway lumen. Soft palate and uvular traits influence airway collapsibility through effects on tissue mass and mechanical compliance.
Neck circumference represents one of the most robust anthropometric predictors of OSA. Increased subcutaneous and visceral fat in the neck region adds mass surrounding the pharyngeal airway, increasing collapsibility. Neck circumference correlates strongly with OSA severity in both men and women.
Body mass index (BMI) shows a dose-dependent relationship with OSA prevalence. Each unit increase in BMI increases OSA odds by about 10%. Weight gain among previously non-apneic individuals frequently precipitates OSA onset. Conversely, significant weight loss greatly improves or resolves OSA in many patients. For more on this topic, see our guide on Tmj Surgery Meniscectomy And Arthroscopy.
Mallampati Scoring and Clinical Assessment
The modified Mallampati scoring system, originally developed to predict difficult intubation, has been adapted to assess oropharyngeal airway space and correlates with OSA risk. The classification system evaluates soft palate, uvula, and tonsillar visibility when the mouth is opened and tongue is fully protruded.
Mallampati Class I (soft palate, uvula, and anterior and posterior tonsillar pillars visible) represents the most open airway and lowest OSA risk. Mallampati Class IV (soft palate not visible, only the base of the tongue visible) represents the most narrowed airway with highest OSA risk.
Mallampati scoring performs best when combined with assessment of other anatomical features, including tonsillar size, uvular position, lateral pharyngeal wall narrowing, and palatal height. Full oropharyngeal check by trained clinicians enables prediction of OSA likelihood with moderate accuracy.
Risk Factors and Population Characteristics
Age represents a consistent OSA risk factor, with disease prevalence increasing progressively from young adulthood through older age. However, OSA can develop at any adult age and increasingly affects younger populations in association with obesity epidemics.
Male gender confers about 2-4 fold increased OSA risk compared to premenopausal women. However, postmenopausal women show OSA prevalence approaching that of men, suggesting hormonal factors modulate OSA risk. Sleep apnea in women is frequently underdiagnosed due to different symptom presentations and clinical recognition bias.
Menopause and postmenopausal hormone status influence OSA risk. Studies show increased OSA prevalence in postmenopausal women compared to premenopausal women, with hormone replacement therapy providing some protective effect.
Obesity, especially central obesity with increased neck circumference, greatly increases OSA risk. The mechanical compression of the pharyngeal airway from increased neck fat mass, combined with reduced plasma volume and altered control of breathing, creates a high-risk phenotype.
Nasal obstruction, chronic rhinitis, and deviated septum contribute to increased upper airway resistance and can precipitate or worsen OSA. Nasal polyps and other nasal pathology similarly increase OSA risk.
Hypothyroidism, polycystic ovary syndrome, and acromegaly all increase OSA prevalence. These conditions involve tissue changes, metabolic alterations, or growth abnormalities that predispose to airway obstruction.
Cardiovascular and Metabolic Consequences
The cardiovascular consequences of untreated OSA are substantial and well-established. Recurrent oxygen desaturation episodes activate sympathetic nervous system activity, leading to increases in blood pressure, heart rate, and myocardial oxygen demand. These acute responses, when repeated hundreds of times nightly, produce chronic sympathetic activation and sustained hypertension. For more on this topic, see our guide on Choosing the Right Night Guard Material - Comfort.
Sleep fragmentation and intermittent hypoxia activate inflammatory pathways, with elevation of pro-inflammatory cytokines, C-reactive protein, and oxidative stress markers. This systemic swelling contributes to vascular endothelial problem and atherosclerotic progression.
Atrial fibrillation develops with increased frequency in OSA patients, with disease severity correlating with arrhythmia prevalence. The arrhythmogenic processes involve sympathetic nervous system activation, hypoxia-induced cardiac irritability, and atrial remodeling from hemodynamic stress.
Myocardial infarction and stroke risks are greatly elevated in OSA patients, even after adjustment for traditional cardiovascular risk factors. Sudden cardiac death rates increase greatly in severe OSA, especially during sleep when patients are most vulnerable.
STOP-Bang Screening Questionnaire
The STOP-Bang questionnaire represents a practical, efficient screening tool for OSA identification in clinical practice. This eight-item questionnaire addresses common OSA symptoms and risk factors.
The STOP component evaluates Snoring (loud snoring), Tiredness (daytime somnolence), Observed apnea (witnessed breathing pauses), and high blood Pressure (hypertension diagnosis). The Bang component assesses BMI >30 kg/m², Age >50 years, Neck circumference, and Gender (male).
Patients responding affirmatively to ≥3 items have high OSA risk and warrant formal diagnostic check. The questionnaire shows soreness of 65-96% for moderate-to-severe OSA detection, depending on the cut-off score applied. Its brevity and ease of use help integration into routine clinical practice.
Daytime Symptomatology and Quality of Life
The Epworth Sleepiness Scale (ESS) quantifies daytime somnolence through patient self-report of sleep likelihood during eight common situations. The 24-point scale shows reasonable correlation with objective sleepiness measures and correlates with OSA severity.
However, numerous OSA patients report minimal daytime somnolence despite severe disease. These "non-sleepy" apneics may present with other symptoms including nocturia, morning headaches, mood disturbance, or cognitive impairment. Absence of reported somnolence should not exclude OSA from diagnostic factor.
Quality of life impairment in OSA extends beyond daytime somnolence. Patients frequently report reduced occupational performance, interpersonal relationship strain, sexual problem, and mood disturbance. These domains of problem persist even when objective sleepiness measures appear mild, highlighting the multifaceted impact of sleep apnea on wellbeing.
Conclusion
Obstructive sleep apnea results from complex interactions between anatomical predisposition, neuromuscular factors, and physiological traits. Understanding pathophysiology enables recognition of risk factors and identification of patients requiring diagnostic check. Screening through tools such as the STOP-Bang questionnaire enables efficient identification of high-risk patients. Recognition of the diverse clinical presentations of OSA beyond daytime somnolence ensures that symptomatic patients receive appropriate check and treatment, reducing the substantial morbidity and mortality associated with untreated disease.
> Key Takeaway: Sleep apnea is when your breathing stops repeatedly during sleep—sometimes dozens or even hundreds of times per night.